Gabapentin Capsule
Product Images NDC 71205-295

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Fig1)

This text provides a formula for calculating "Lt" using the age and weight of a patient, as well as their creatinine levels (with a specific value given for female patients). However, without further context or information, the exact purpose or significance of this calculation is not available.*

FDA Label Image

Figure 1 (Gabapentin Fig2)

This appears to be a chart or graph that shows the mean pain score at different time points during a clinical trial for a medication. Gabapentin, at a dose of 3600 mg/day, was compared to a placebo. The chart shows a baseline measurement followed by weeks 1-7 of the trial. The numbers on the vertical axis represent the pain score, while the horizontal axis shows the timeline of the trial.*

FDA Label Image

Figure 2 (Gabapentin Fig3)

This appears to be a chart or table related to a study on pain management. It includes columns for "Mean Pain Score," "Baseline," and various doses of gabapentin. Without further context or information, it's difficult to provide a more detailed or useful description of the text.*

FDA Label Image

Figure 3 (Gabapentin Fig4)

This is a clinical trial study with different percentages of patients who have a reduction in pain score. The figure shows the proportion of responders in controlled PHN studies. The table below the figure indicates the results obtained in Study 1 and Study 2 where there are different treatments: Placebo (PBO), Gabapentin 1800 mg/day (GBP 1800), Gabapentin 2400 mg/day (GBP 2400), and Gabapentin 3600 mg/day (GBP 3600). The symbol '#p<00l 5D < 0,001' is probably related to statistical significance.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

FDA Label Image

71205-295-30 (Gabapentin Fig7)

This is a bottle of Gabapentin 300mg containing 30 capsules manufactured by Aurobindo Pharma Limited in India and distributed by ProficientRx in Thousand Oaks, CA. The capsules are yellow with the imprint "O03" and contain white to off-white crystalline powder. The product ID is QG029530 and the GTIN number is 0371205295301. The lot number of this particular bottle is 00000 with an expiration date of 00/00/00. It is RX only and comes with a medication guide that should be provided separately to each patient. The medication should be stored at 20°-25°C (68°-77°F) and kept out of reach of children.*

FDA Label Image

Chemical Structure (Gabapentin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.